Key points {#Sec1}
==========

**Question**: Is High-density Lipoprotein Cholesterol Concentration associated with acute kidney injury after non-cardiac surgeries?

**Finding**: The odds ratio for HDL (0.96--1.14 as reference, \< 0.96, 1.14--1.35, \> 1.35) was 1.28 (1.14--1.41), *P* \< 0.001; 0.91 (0.80--1.03), *P* = 0.150; 0.75 (0.64--0.85), P \< 0.001, respectively.

**Meaning**: low HDL cholesterol levels were independent risk factors for AKI after non-cardiac surgery.

Background {#Sec2}
==========

Acute kidney injury (AKI) is a common complication after both cardiac and non-cardiac surgery. The prevalence of AKI varies greatly, from 1.1% of patients after the minimally invasive procedures to 17.9% of patients following major surgeries \[[@CR1]--[@CR9]\]. The patients' mortality rate increases significantly with the occurrence of AKI.^3--5^ There are many risk factors associated with AKI. These include factors that cannot be modified, for example, gender, body mass index (BMI), age, time and complexity of the surgery. And factors that can be modified, for example, preoperative albumin levels, duration of hypotension, colloid and dexmedetomidine use \[[@CR1]--[@CR7]\].

Recent studies found that after major cardiac surgery the concentration of High-density Lipoprotein Cholesterol Concentration (HDL) was associated with AKI\[[@CR10]\]. However, no studies were found regarding AKI after non-cardiac surgery. The present research aims to determine the relationship between AKI and the concentration of and AKI after non-cardiac surgery.

Methods {#Sec3}
=======

Study design {#Sec4}
------------

This study was approved by the Peking University First Hospital Ethics Committee, and the requirement for written informed consent was waived.

Data source and study patients {#Sec5}
------------------------------

This study used data obtained from the perioperative database of Peking University First Hospital, which contains the perioperative information of inpatients from 2012 onward. This study analyzed data from adults (age ≥ 18 years old) who underwent elective non-cardiac surgery between January 1, 2012, and December 31, 2017. Non-cardiac non-kidney surgery was identified based on the International Classification of Diseases and Procedures, Ninth Clinical Revision Revision volume 3 (ICD-9-v3). All surgeries other than those with their ICD codes listed were defined as "other." (Table S[1](#MOESM1){ref-type="media"} in the Supplementary Appendix).

Patients were excluded from the study based on the following criteria, those that underwent cardiac surgeries, kidney surgeries, obstetric surgeries, local infiltration anesthesia, and missing perioperative data. Also, patients with more than one operation within a year (including reopening of surgical cases) were excluded.

The patients' preoperative serum cholesterol levels were obtained from the laboratory database and linked to the hospital's perioperative database. Results were categorized according to the day on which patients' were operated on. The mean value (3 month time frame) was calculated for each patient with more than one preoperative result.

Study ENDPOINTS {#Sec6}
---------------

The endpoint was any patient with AKI within 7 days in the hospital. This study used KDIGO as the criteria for AKI, which was defined by the patient's postoperative serum creatinine increase to not less than 26.5 μmol/l within 48 h, or 1.5 times from the baseline within 7 days after surgery, or initialization of blood dialysis. As the serum creatinine level fluctuates much postoperatively and could cause an inaccurate estimate of Glomerular Filtration Rate (eGFR), this study did not define AKI based on the GFR value or urine output.

Statistical analysis {#Sec7}
--------------------

According to previous studies, the incidence of postoperative AKI would be 1.1--17.9% in patients that elected to have surgery \[[@CR1]--[@CR9]\]. We expected the patients with an abnormal serum cholesterol level to have an OR of 1.20 when compared with the normal serum cholesterol level. With significance set at 0.05 and the power set at 90%, the calculated sample size needed to compare two proportions was 3206 patients in each group.

For the comparative analysis, patients were divided into two groups according to the occurrence of postoperative AKI. Continuous variables with a normal distribution were compared using the Student t-test, and those with non-normal distribution were compared with the Mann-Whitney U-test. The Kolmogorov-Smirnov test was used to determine whether the data were normally distributed or not. Categorical variables were compared using the Chi-Square test or continuity corrected Chi-Square test. Rank variables were compared using the Kruskal--Wallis H-test.

Logistic regression was used to detect any association between the concentrations of HDL and AKI {#Sec8}
------------------------------------------------------------------------------------------------

A logistic regression model was constructed using the following formula: $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \mathrm{AKI}=\mathrm{HDL}+\mathrm{confounders} $$\end{document}$$

Confounders (covariates) were the same in both the logistic regression and generalized additive models, except for the HDL levels. Confounders were assessed based on a priori knowledge and other studies \[[@CR1]--[@CR9], [@CR11]\]. The following covariates were considered: sex, age, BMI, revised cardiac risk index grade, surgery duration, anesthesia type, cancer surgery, intraoperative blood transfusion, surgical complexity (Modified John Hopkins hospital criteria, MJHSC, \[[@CR12]\]. Table-S[5](#MOESM1){ref-type="media"} in Appendix supplement 1) and preoperative serum albumin and serum creatinine, anesthesiologist's experience, intraoperative dexmedetomidine and colloid use.

The propensity score weighting analysis {#Sec9}
---------------------------------------

Due to the huge systematic differences, this study balanced the patients with preoperative HDL below or above 1.03 mmol/L (the widely accepted threshold for cardiovascular risk \[[@CR13]\]) by propensity score weighting. Propensity score weighting is a method to diminish the effect of measured confounding factors and to get a less biased result in observational studies. In the present study, propensity score weights were calculated by using gradient boosted regression models,\[[@CR14], [@CR15]\] in which high or low preoperative HDL was the dependent variable, and vectors of the following (age, gender, body mass index, revised cardiac risk index, surgery duration, anesthesia type, cancer surgery, intraoperative blood transfusion, surgical complexity, type of surgery classified by site, anesthesiologist's experience, severe intraoperative hypotension, preoperative coronary heart disease, arrhythmia, cerebral infarction, diabetes, chronic kidney disease, preoperative creatinine, cholesterol components, intraoperative dexmedetomidine and colloid use) were the independent variables. Compared to the inverse probability of exposure weighting method (IPEW), \[[@CR16]\] the propensity score weights calculated by the gradient boosted regression models do not need to consider co-linearity and often get better balancing performance \[[@CR14], [@CR15]\]. Using the weights for the originally observed cohorts could create two new cohorts with the number of patients differing from the original, and may not be an integer (each patient was multiplied by a specific weight defined by the gradient boosted regression models). The logistic analysis with the propensity score weighting could lead to less biased results, i.e., a quasi-randomized study.

Statistical packages {#Sec10}
--------------------

All data management and statistical analysis were performed using the R programming language (v.3.5.2).

Result {#Sec11}
======

Study population {#Sec12}
----------------

This study identified 60,772 non-cardiac non-kidney and non-obstetric elective surgeries from 57,983 unique patients between January 1, 2012, and December 31, 2017 (Figure-S[1](#MOESM1){ref-type="media"} in the supplement). A total of 2649 (4.4%) cases had postoperative AKI, of which, 2192,152, and 305 cases were AKI grades 1, 2 and 3, respectively. Compared to those without it, patients with postoperative AKI were older, were more likely to be male, have a low body mass index, have a co-existing disease, have high blood pressure, and to be in a lengthy surgery (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). (Table S[1](#MOESM1){ref-type="media"} in the Supplementary) Table 1Demographic characteristics and preoperative comorbiditiescharacteristicALL\
(***n*** = 60,772)No AKI\
(***n*** = 58,123)AKI\
(***n*** = 2649)***P*** valueAge56.2 ± 15.855.9 ± 15.862.5 ± 14.5\< 0.001Gender, female37,226(49.2%)36,120(49.8%)1106(35.0%)\< 0.001Body mass index, kg/m^2^24.5 ± 3.724.5 ± 3.724.5 ± 4.00.936Co-existing disease hypertension21,236(28.0%)19,889(27.4%)1347(42.6%)\< 0.001 Coronary artery disease3938(5.2%)3588(4.9%)350(11.1%)\< 0.001 Heart failure704(0.9%)575(0.8%)129(4.1%)\< 0.001 Stroke3092(4.1%)2833(3.9%)259(8.2%)\< 0.001 diabetes mellitus9184(12.1%)8516(11.7%)668(21.1%)\< 0.001 Renal insufficiency1009(1.3%)561(0.8%)448(14.2%)\< 0.001 Regular statin therapy^a^900(0.8%)822(0.8%)78(1.6%)\< 0.001ASA I18,472(24.4%)18,181(25.1%)291(9.2%)\< 0.001 II51,065(67.6%)49,093(67.8%)1972(62.6%) III5900(7.8%)5057(7.0%)843(26.8%) IV138(0.2%)95(0.1%)43(1.4%)Results reported as mean ± SD or n (%)a: Only regular statin therapy with more than 3 months was countTable 2perioperative parameterscharacteristicALL\
(n = 60,772)No AKI\
(n = 58,123)AKI\
(n = 2649)*P* valueAnesthesia duration, min189.7 ± 123.0187.2 ± 121.3244.7 ± 146.0\< 0.001Anesthesia type\< 0.001General anesthesia48,273(77.9%)46,117(77.8%)2156(81.0%)General anesthesia + epidural/nerve block4044(6.5%)3791(6.4%)253(9.5%)Neuraxial or nerve block9642(15.6%)9388(15.8%)254(9.5%)Infusion volume, ml1100(750--1800)1100(700--1700)1600(1100--2600)\< 0.001Crystal, ml1100(600--1600)1000(600--1600)1300(1000--2100)\< 0.001Colloid, ml0(0--500)0(0--500)0(0--500)\< 0.001Estimated blood loss, ml0(0--50)0(0--50)30(0--200)\< 0.001Intraoperative blood infusion5725(9.2%)5263(8.9%)462(17.3%)\< 0.001Urine, ml0(0--300)0(0--300)100(0--400)\< 0.001Surgery time, min117.5 ± 123.9115.8 ± 121.6156.0 ± 163.2\< 0.001Surgery type\< 0.001Eye/ear/throat3089(5.0%)3054(5.2%)35(1.3%)Integumentary2221(3.6%)2181(3.7%)40(1.5%)Genital/urinary16,264(26.2%)15,150(25.5%)1114(41.8%)Musculoskeletal7390(11.9%)7153(12.1%)237(8.9%)Nervous3545(5.7%)3412(5.8%)133(5.0%)Vascular2233(3.6%)2160(3.6%)73(2.7%)Digestive20,936(33.8%)20,094(33.9%)842(31.6%)Respiratory3528(5.7%)3395(5.7%)133(5.0%)Other2753(4.4%)2697(4.5%)56(2.1%)Intraoperative mean HR, bpm65.7 ± 9.865.6 ± 9.767.4 ± 10.9\< 0.001Baseline SBP, mmHg127.8 ± 17.7127.6 ± 17.6132.1 ± 18.7\< 0.001Baseline DBP, mmHg76.5 ± 10.976.5 ± 10.877.4 ± 11.9\< 0.001KDIGO AKI grade III306(0.8%)--306(11.5%)\< 0.001 II154(0.4%)--154(5.8%)\< 0.001 I2203(5.8%)--2203(82.7%)\< 0.001

Results of the logistic regression to detect any association between the concentrations of HDL and AKI {#Sec13}
------------------------------------------------------------------------------------------------------

The results of the multivariate logistic regression showed an association between low HDL and postoperative AKI. The odds ratio for HDL (0.96--1.14 as reference, \< 0.96, 1.14--1.35, \> 1.35) was 1.28 (1.14--1.41), *P* \< 0.001; 0.91 (0.80--1.03), *P* = 0.150; 0.75 (0.64--0.85), P \< 0.001, respectively. (Table [3](#Tab3){ref-type="table"}) Table 3Association detection with logistic regression models and causal inference after propensity score weighting analysisCut value (mmol/l)Odds ratio by multivariate logistic regressionP valueBefore or after propensity score weightingModel 1^a^0.96--1.14referencebefore\< 0.961.28 (1.14 \~ 1.41)\<.0011.14--1.350.91 (0.80 \~ 1.03)0.15\> 1.350.75 (0.64 \~ 0.85)\<.001Model 2^b^\<  1.03 vs ≥ 1.031.40 (1.27 \~ 1.52)\<.001beforeModel 3^c^\<  1.03 vs ≥ 1.031.32 (1.21--1.46)\<.001aftera: multivariate logistic regression model without propensity score weighting, the HDL was cut by quantileb: multivariate logistic regression model without propensity score weighting, the HDL was cut by 1.03 mmol/l.c: multivariate logistic regression model after propensity score weighting, the HDL was cut by 1.03 mmol/l.

Results of the propensity score weighting analysis {#Sec14}
--------------------------------------------------

After the propensity score weighting, the data set was divided into two groups i.e. patients with an HDL level above and below the predetermined HDL cholesterol value of 1.03 mmol/L which was obtained from previously published studies \[[@CR13]\]. Also, the logistic odds ratio was calculated. The odds ratio for HDL (\> 1.03 as reference) was 1.32 (1.21 - 1.46), *P* \< 0.001. (Table [3](#Tab3){ref-type="table"}) (Tables S[2](#MOESM1){ref-type="media"}, S[3](#MOESM1){ref-type="media"}, S[4](#MOESM1){ref-type="media"} in the Supplementary).

Sensitivity analysis {#Sec15}
--------------------

Different cutoff points were used to reanalyze the association between the concentration of HDL and AKI, and similar results to the propensity score weighting analysis were found. (Table S5 in the Supplementary).

Discussion {#Sec16}
==========

This study showed that postoperative AKI was 4.4% of adult patients undergoing elective non-cardiac surgery. Multi-variable adjustment before or after propensity score weighting showed that low concentrations of HDL was strongly associated with AKI following non-cardiac surgery. After adjusting for other risk factors, low HDL was still an independent risk factor for cardiovascular disease \[[@CR17]--[@CR22]\]. However, an increase in HDL did not reduce cardiovascular events, and there was no causal relationship between them \[[@CR23]--[@CR26]\]. The MESA cohort study found that HDL particles were more predictive of cardiovascular events than HDL cholesterol, suggesting that certain structures and features of HDL play key roles \[[@CR21]\]. There appeared to be no causal relationship between HDL cholesterol levels and cardiovascular disease.

This study found that after non-cardiac surgery, preoperative HDL levels were independent risk factors for postoperative AKI. After the balancing of possible confounding factors and other cholesterol and triglycerides levels, the results still showed that HDL was closely related to postoperative AKI.

The mechanism by which HDL protects the patient against postoperative AKI is not clear. The mechanisms related to HDL and cardiovascular events include macrophage cholesterol efflux \[[@CR24], [@CR27]\]; promoting maintenance of endothelial function \[[@CR28], [@CR29]\]; protection against oxidation of LDL \[[@CR30], [@CR31]\]; protection against inflammation \[[@CR32]\]; immunomodulation \[[@CR33]\]; and finally, via a variety of actions, interfering with the thrombotic component of atherosclerosis \[[@CR34]--[@CR37]\]. These mechanisms may also play a role in the prevention of AKI. There may be other mechanisms specific to the kidney currently not known and needing further research. Studies have reported that the dysfunction of HDL's anti-inflammation, anti-oxidation, and endothelial protection are associated with an increased risk of chronic renal disease \[[@CR38]--[@CR40]\].

Researchers have found that serum HDL is high, antioxidant enzymes and oxidative stress levels are reduced, which was related to receptors acting as pro-oxidant lipids \[[@CR41]--[@CR44]\]. Moreover, high HDL was related to decreased expression of adhesion molecules, increased nitric oxide, and decreased damage to the endothelium \[[@CR42], [@CR45], [@CR46]\]. In patients with chronic kidney disease, the function of their HDL as an anti-inflammatory, antioxidant and protector of their endothelial, was found to be decrease \[[@CR40], [@CR47]--[@CR49]\]. These processes (systemic inflammation, oxidative stress, and endothelial dysfunction and damage) all play a key role in postoperative renal dysfunction and AKI.

Our study found that the preoperative use of a statin did not reduce postoperative AKI. This is consistent with previous multiple high-quality studies \[[@CR50]--[@CR52]\]. Recently, one study suggested that long-term use of a statin can enhance the protection by HDL \[[@CR10]\]. These contradictory results suggest that the protective effect of statins on the kidney is not direct and requires further research.

AKI results in a higher mortality rate, longer hospitalization, and increased costs. It is of paramount importance to focus on the possible risk factors related to AKI that can be managed. For those at high risk, earlier lab tests, medication selection, and measures to protect the kidney may improve the prognosis with minimal cost and medical resources required.

Some research found high HDL was related to longer life expectancy. The importance and mechanism of HDL throughout the human body still not fully understood. Our research proposes a possible research direction on HDL.

Although the authors tried their best to implement the best research methods and improve the quality of the database, various shortcomings and errors were still inevitable, including: 1. This study was a retrospective cohort study, which may result in inaccuracies. 2. Postoperative laboratory tests and exams were not performed on every patient but were based on clinical observations when symptoms and signs were suspected, which may result in an underestimation of the primary outcome rate. A few patients were discharged from the hospital within 7 days of their surgeries, without any subsequent following. There may be a small number of patients with primary outcome events that were not detected.

Conclusion {#Sec17}
==========

Using multivariate regression analyses before and after propensity score weighting in addition to multiple sensitivity analysis methods, this study found that following non-cardiac surgery, low HDL cholesterol levels were independent risk factors for AKI.
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AKI

:   Acute kidney injury

LDL

:   Low-density lipoprotein cholesterol

HDL

:   High-density lipoprotein cholesterol

TG

:   Triglycerides

ICD-9-v3

:   INTERNATIONAL Classification of diseases and procedures, Ninth Revision Clinical Revision volume 3

ICD

:   International Classification of diseases and procedures

eGFR

:   Estimated Glomerular Filtration Rate

MJHSC

:   Modified John Hopkins hospital criteria
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